Zacks Research also recently recommended this genetic information company stock based on rising sales and increasing analyst price targets.
Invitae Corporation (NVTA)
From Cabot Stock of the Week
Invitae Corporation (NVTA), originally recommended by Mike Cintolo in Cabot Top Ten Trader, hit a record high two weeks ago and then last week pulled back to test its 50-day moving average—from which it has now rebounded.
Last week, in Cabot Growth Investor, Mike wrote, “NVTA got smacked around with just about every medical related stock on Wednesday, but the action still looks normal to us. In fact, some steadying around here and a push higher in the stock could offer a solid entry point, though we’d probably start with a half position given the stock’s volatility.” BUY.
Timothy Lutts, Cabot Stock of the Week, www.cabotwealth.com, 978-745-5532, April 23, 2019